Spire Healthcare Group (LON:SPI) Price Target Lowered to GBX 100 at Royal Bank of Canada
Spire Healthcare Group (LON:SPI) had its price target reduced by Royal Bank of Canada from GBX 149 ($1.96) to GBX 100 ($1.32) in a research note released on Wednesday, Stock Target Advisor reports. They currently have an outperform rating on the stock.
SPI has been the subject of several other research reports. Jefferies Financial Group cut shares of Spire Healthcare Group to an underperform rating and lifted their price target for the stock from GBX 106 ($1.39) to GBX 113 ($1.49) in a research report on Tuesday, January 21st. Peel Hunt reiterated an add rating on shares of Spire Healthcare Group in a research report on Friday, March 13th. Barclays reiterated an underweight rating on shares of Spire Healthcare Group in a research report on Tuesday, January 7th. Peel Hunt reiterated an add rating and set a GBX 155 ($2.04) price target on shares of Spire Healthcare Group in a research report on Wednesday, January 8th. Finally, Liberum Capital reiterated a hold rating on shares of Spire Healthcare Group in a research report on Wednesday. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the company. The stock currently has an average rating of Hold and a consensus price target of GBX 130.44 ($1.72).
Shares of LON:SPI traded up GBX 0.05 ($0.00) during trading on Wednesday, hitting GBX 52.60 ($0.69). 5,252,477 shares of the company’s stock were exchanged, compared to its average volume of 1,770,000. Spire Healthcare Group has a 1-year low of GBX 61.25 ($0.81) and a 1-year high of GBX 145 ($1.91). The firm has a 50-day moving average price of GBX 114.54 and a two-hundred day moving average price of GBX 121.36. The company has a current ratio of 1.03, a quick ratio of 0.77 and a debt-to-equity ratio of 124.33. The firm has a market cap of $210.97 million and a P/E ratio of 29.22.
Spire Healthcare Group Company Profile
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.